Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas

Acta Neuropathologica

Volumn 91, Issue 5, 1996, Pages 504-510

  Matsuno, Akira ^a   Fujimaki, Takamitsu ^b   Sasaki, Tadashi ^b   Nagashima, Tomio ^a   Ide, Takafumi ^b   Asai, Akio ^b   Matsuura, Reiko ^b   Utsunomiya, Hirotoshi ^c   Kirino, Takaaki ^b  

^a TEIKYO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Ki 67; Meningioma; MIB 1; Proliferative potential; Recurrence

Indexed keywords

MONOCLONAL ANTIBODY; PARAFFIN;

ADULT; AGE; ARTICLE; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL ANALYSIS; TUMOR RECURRENCE;

ADULT; AGE FACTORS; ANTIGENS, NUCLEAR; CELL DIVISION; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; SEX FACTORS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0029991886     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050458     Document Type: Article

References (25)

1. Adegbite AB, Kahn MI, Paine KWE, Tan LK (1983) The recurrence and intracranial meningiomas after surgical treatment. J Neurosurg 58 : 51-56
2. Bagni A, Botticelli A, Martinelli A, Azzoni P, Trentini GP (1991) AgNOR counts in recurrent and non-recurrent meningiomas. Histopathology 19 : 465-467
3. Cattoretti G. Becker MHG, Key G, Duchrow M, Schlüter C. Galle C, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168 : 357-363
4. Chan RC. Thompson GB (1984) Morbidity, mortality and quality of life following surgery for intracranial meningiomas. J Neurosurg 60 : 52-60
5. Chin LS, Hinton DR (1991) The standardized assessment of argyrophilic nucleolar organizer regions in meningiomas. J Neurosurg 74 : 590-596
6. Christensen D, Laursen H, Klinken L (1983) Prediction of recurrence of meningiomas after surgical treatment: a quantitative approach. Acta Neuropathol (Berl) 61 : 130-134
7. Crompton MR, Gautier-Smith PC (1970) The prediction of recurrence in meningiomas. J Neurol Neurosurg Psychiatry 33 : 80-87
8. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133 : 1710-1715
9. Gupta PK, Sastry Kolluri VR, Das S, Chandra Mouli BA, Narayana Swamy KS, Dan BS (1989) Recurrences in meningiomas after surgery. Acta Neurochir (Wien) 100 : 104-109
10. Hoshino T, Nagashima T, Murovic JA, Wilson CB, Davis RL (1986) Proliferative potential of human meningiomas of brain. Cancer 58 : 1466-1472
11. Jaaskelainen J, Haltia M, Servo A (1986) Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25:233-242
12. Jellinger K, Slowik F (1975) Histological subtypes and prognostic problems in meningiomas. J Neurol 208 : 279-298
13. Karamitopoulou E, Perentes E, Melachrinou M, Maraziotis T (1993) Proliferating cell nuclear antigen immunoreactivy in human central nervous system neoplasms. Acta Neuropathol 85 : 316-322
14. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T (1994) Ki-67 immunoreactivity in human central nervous system neoplasms: a study with MIB-1 monoclonal antibody on archival material. Acta Neuropathol 87 : 47-54
15. Kleihues P, Burger PC, Scheithauer BW (1993) The new WHO classification of brain tumors. Brain Pathol 3 : 255-268
16. Marks SM, Whitwell MB, Richard HL (1986) Recurrence of meningiomas after operation. Surg Neurol 25 : 436-440
17. Melamed S, Sahar A, Beller AJ (1979) The recurrence of intracranial meningioma. Neurochirurgia 22 : 47-51
18. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL (1985) Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 62 : 18-24
19. Ohta M, Iwaki K, Kitamoto T, Takeshita I, Tateishi J, Fukui M (1994) MIB1 staining index and scoring of histologic features in meningiomas: indicators for the prediction of biologic potential and proliferative management. Cancer 74 : 3176-3189
20. Orita T, Kajiwara K, Nishizaki T, Ikeda N, Kamiryo T, Aoki H (1990) Nucleolar organizer regions in meningioma. Neurosurgery 26 : 43-46
21. Paulus W, Meixensberger J, Hofmann E, Roggendorf W (1993) Effect of embolisation of meningioma on Ki-67 proliferation index. J Clin Pathol 46 : 876-877
22. Shibuya M, Hoshino T, Ito S, Wacker MR, Prados MD, Davis RL, Wilson CB (1992) Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling. Neurosurgery 30 : 494-498
23. Shibuya M, Utsunomiya H, Osamura RY (1993) Identification of cells in proliferative phases using MIB-1 immunohistochemical method: antigen retrieval in paraffin sections (in Japanese). Pathol Clin Med 11 : 373-377
24. Shibuya M, Ito S, Miwa T, Davis RL, Wilson CB, Hoshino T (1993) Proliferative potential of brain tumors. Analyses with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nuclear organizer region counts. Cancer 71 : 199-206
25. Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20 : 22-39